CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • March 10th, 2020 • Principia Biopharma Inc. • Pharmaceutical preparations • California
This Change in Control and Agreement (the “Agreement”) is dated as of April 18, 2019, by and between Dolca Thomas, M.D. ("Executive") and Principia Biopharma, Inc., a Delaware corporation, including its subsidiaries (the "Company"), effective as of October 22, 2018 (the “Effective Date”). This Agreement is intended to provide Executive with certain benefits described herein upon the occurrence of specific events.
